How did Medline reconcile 12% top-line growth and a raised organic sales outlook with a lower full-year adjusted EBITDA guidance in Q2 2026?
The short reconciliation Medline did not say the strong quarter automatically meant a stronger full year. In the same report, it raised one forecast and cut another because the two forecasts were affected by different things: organic sales reflected demand, while adjusted EBITDA guidance reflected costs, investments, and a special...
3000